Ro48-6791

This MedLibrary.org supplementary page on Ro48-6791 is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Ro48-6791
Systematic (IUPAC) name
3-(5-dipropylaminomethyl-1,2,4-oxadiazol-3-yl) -8-fluoro-5-methyl-5,6-dihydro-4H-imidazo[1,5-a] [1,4]benzodiazepin-6-one
Identifiers
CAS number  ?
ATC code  ?
PubChem  ?
Chemical data
Formula C21H25FN6O2 
Mol. mass 412.47
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Ro48-6791 is a drug which is a benzodiazepine derivative developed by Hoffman-LaRoche in the 1990s.

Ro48-6791 was developed as an alternative to the short acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures. Ro48-6791 has similar properties to midazolam, being water soluble, with a fast onset and short duration of action. It is 4-6x more potent than midazolam,[1] and slightly shorter acting,[2] and produces similar side effects such as sedation and amnesia.

It was tested up to Phase II human trials, but while it produced less respiratory depression than propofol, it had a longer recovery time and was deemed not to have any significant advantages over the older drug.[3] Similarly when Ro48-6791 was compared to midazolam, it had similar efficacy, higher potency and a shorter recovery time, but produced less of a synergistic effect on opioid-induced analgesia and produced more severe side effects such as dizziness after the procedure.[4] Consequently it was dropped from clinical development,[5] although it is still used in scientific research.[6]



References

  1. ^ Dingemanse J, van Gerven JM, Schoemaker RC, Roncari G, Oberyé JJ, van Oostenbruggen MF, Massarella J, Segala P, Zell M, Cohen AF. Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects. British Journal of Clinical Pharmacology. 1997 Nov;44(5):477-86. PMID 9384465
  2. ^ Hering W, Ihmsen H, Albrecht S, Schwilden H, Schüttler J. Ro 48-6791 - a short acting benzodiazepine. Pharmacokinetics and pharmacodynamics in young and old subjects in comparison to midazolam. Anaesthesist. 1996 Dec;45(12):1211-4. PMID 9065257
  3. ^ Wrigley PJ, Elliott DW, Blake D. A phase 2 clinical trial comparing Ro 48-6791, a new short-acting benzodiazepine, with propofol for induction of anaesthesia. Anaesthesia and Intensive Care. 1998 Oct;26(5):509-14. PMID 9807605
  4. ^ Tang J, Wang B, White PF, Gold M, Gold J. Comparison of the sedation and recovery profiles of Ro 48-6791, a new benzodiazepine, and midazolam in combination with meperidine for outpatient endoscopic procedures. Anesthesia and Analgesia. 1999 Oct;89(4):893-8. PMID 10512261
  5. ^ Gold ME, Todd SA, Spiegler C, Gold JA. When the drug trial fails: an approach to clinical drug studies. AANA Journal. 1999 Dec;67(6):505-12. PMID 10876442
  6. ^ Ihmsen H, Albrecht S, Hering W, Schüttler J, Schwilden H. Modelling acute tolerance to the EEG effect of two benzodiazepines. British Journal of Clinical Pharmacology. 2004 Feb;57(2):153-61. PMID 14748814

Wikipedia content modification information:

  • This page was last modified on 12 May 2008, at 09:11.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Ro48-6791".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.